key: cord-1039153-4149gjkl authors: Goncu Ayhan, Sule; Oluklu, Deniz; Atalay, Aysegul; Menekse Beser, Dilek; Tanacan, Atakan; Moraloglu Tekin, Ozlem; Sahin, Dilek title: COVID‐19 vaccine acceptance in pregnant women date: 2021-05-01 journal: Int J Gynaecol Obstet DOI: 10.1002/ijgo.13713 sha: 63b238f0c13fe6aaf0f1e06a9f539d475b6ffd0b doc_id: 1039153 cord_uid: 4149gjkl OBJECTIVE: To determine vaccine acceptance and hesitancy attitudes toward coronavirus disease 2019 (COVID‐19) vaccines in pregnant women. METHODS: Three hundred pregnant women were surveyed face to face with 40 questions. Sociodemographic characteristics, vaccination history, perception of risk for the COVID‐19 pandemic, the impact of the COVID‐19 pandemic, and acceptance of and attitude toward future COVID‐19 vaccination were prospectively evaluated. RESULTS: Among all participants, 111 (37%) stated their intent to receive the vaccine if it were recommended for pregnant women. Most common refusal reasons were lack of data about COVID‐19 vaccine safety in pregnant populations and possibility of harm to the fetus. There was a weak positive correlation between COVID‐19 vaccine acceptancy and number of school‐age children. Pregnant women in the first trimester expressed higher acceptance of COVID‐19 vaccination than those in the second and third trimesters. CONCLUSION: The present study reported low acceptance of COVID‐19 vaccination in a sample of pregnant women. Concern about vaccine safety was the major reason for hesitancy. Identifying attitudes among priority groups will be useful for creating vaccination strategies that increase uptake during the current pandemic. Pregnant women are at increased risk of severe disease, intensive care unit admission, and invasive ventilation when compared with non-pregnant patients of the same age. [6] [7] [8] Therefore, pregnant women are classified as a high-risk population for COVID-19 infection. 9 Regarding this information, pregnant women have not been included in any COVID-19 vaccine clinical trials to date. 10 Even so, public health authorities, including the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine recommend that COVID-19 vaccines should be available for pregnant women if they prefer to be vaccinated. 11, 12 The confusion surrounding pregnant women has interfered with decision making about the COVID-19 vaccination. We hypothesized that pregnant women would avoid the COVID-19 vaccine because of the inconsistent available data. Our study aims to define COVID-19 vaccine acceptance and hesitancy status in a sample of pregnant women in Ankara, Turkey. This prospective study was conducted in Ankara City Hospital between January 1, 2021 and February 1, 2021 with pregnant women who were seen for prenatal care. Data were collected using a faceto-face questionnaire. Written informed consent was obtained from all participants. The applied protocol was approved by the Turkish Indications of a high-risk pregnancy included preterm labor, gestational hypertension, gestational diabetes mellitus, fetal structural anomalies, multifetal pregnancy, epilepsy, and placenta previa. Statistical analyses were performed using SPSS 17 (SPSS Inc., Chicago, IL, USA). The Shapiro-Wilk test and Kolmogorov-Smirnov test were used to determine the distribution of normality, and χ 2 test was used to compare categorical data. The continuous variables were presented as mean and standard deviations. Groups were compared with Spearman's rho test for correlation between sociodemographic variables and COVID-19 vaccine acceptance. A type-1 error below 0.05 was considered statistically significant. Coronavirus disease 2019 vaccine acceptance rates and comparisons of the answers of patients with high-risk and low-risk pregnancies are given in Table 2 . We did not find a significant difference between high-risk and low-risk groups. A summary of the reasons for refusing the COVID-19 vaccine is given in Table 3 . Pregnant women who said they would refuse the vaccine stated their most important concerns as: (1) a lack of data about COVID-19 vaccine safety in the pregnant population, and (2) the possibility of harm to the fetus. The correlation between COVID-19 vaccine acceptance and sociodemographic features is presented in Table 4 . A weak positive correlation was observed between COVID-19 vaccine acceptance and the number of school-age children in the household (P < 0.05). When we compared first-trimester pregnant women with second-and third-trimester pregnant women, women in their first trimester expressed greater interest in receiving the COVID-19 vaccination than others (P < 0.05). The present study reported low acceptance of COVID-19 vaccina- vaccine acceptance and refusal groups were compared, the refusal group expressed lower influenza vaccine acceptance. This result is consistent with vaccine hesitancy, which has been a growing problem in public health over the last decade. 4 Özceylan et al. 13 The greatest concern about the COVID-19 vaccine in the re- 19, 20 Anxiety was more prevalent in high-risk pregnant women compared with low-risk pregnant women. 21 We thought that this anxiety level might induce COVID-19 vaccine acceptance in high-risk pregnant women, but we did not find a difference in COVID-19 vaccine acceptance between high-risk and low-risk groups. We did find greater influenza and tetanus vaccine acceptance in the high-risk group compared with the low-risk group. Lack of COVID-19 vaccine safety data in pregnancy may have contributed to this finding. Among respondents who were experiencing a low-risk pregnancy and who refused vaccination, three main reasons for refusal emerged: Numerous studies have demonstrated that the best approach to protect neonates during early infancy is through passive placental antibody transfer by vaccine efficacy. 18, 25 However, almost half of pregnant women refusing the vaccine cited potentially harmful effects of the COVID-19 vaccine to their fetus as a reason for refusal. Once again the importance of proper explanation about the vaccine becomes significant. The main strengths of the present study were its novelty, prospective design, and number of study parameters. In conclusion, the benefits of the COVID-19 vaccine are promising and it is recommended by health authorities for administration during pregnancy. To the best of our knowledge, this is the first study evaluating attitudes of pregnant women toward the COVID-19 vaccine. Concern about vaccine safety is a major obstacle to vaccination, especially for newly developed vaccines. Tetanus toxoid vaccines have been used for years to prevent infectious morbidity, which is known to negatively impact maternal and neonatal health. We believe that pregnant women should be included in vaccine trials as soon as possible. Identifying attitudes among priority groups will be useful to create vaccination strategies in the prevention and control of COVID-19. Special thanks go to all healthcare staff who have worked with devotion to improve the health standards of patients during the pandemic period. The authors have no conflicts of interest. SGA prepared and wrote the original draft and contributed to data collection. DO contributed to data collection, analysis and interpretation. AA and DMB contributed to data collection. AT performed the literature search. OMT performed the project development. DS was responsible for conceptualization, methodology, visualization, and reviewing and editing. Sule Goncu Ayhan https://orcid.org/0000-0002-5770-7555 The eradication of polio: have we succeeded? Vaccine Measles-the epidemiology of elimination A review of the progress and challenges of developing a vaccine for COVID-19 Factors influencing pandemic influenza vaccination of healthcare workers-a systematic review Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and metaanalysis COVID-19 positive woman presented with preterm labor: case report Pregnancy outcome in first 50 sars-cov-2 positive patients at our center Control CfD, Prevention. People with certain medical conditions. Morbidity and Mortality Weekly Report CDC. 2020 Exclusion of pregnant women from clinical trials during the coronavirus disease 2019 pandemic: a review of international registries Infectious Disease, and Public Health Preparedness Expert Work Group in collaboration with Society for Maternal-Fetal Medicine (SMFM) statement: SARS-CoV-2 vaccination in pregnancy Vaccine rejection and hesitation in Turkey. Hum Vaccines Immunother Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices (ACIP) The rate of influenza vaccination after face-to-face interview in pregnancy Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn The Advisory Committee on Immunization Practices' Interim Recommendation for use of Pfizer-BioNTech COVID-19 vaccine-United States Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials Does having a high-risk pregnancy influence anxiety level during the COVID-19 pandemic? A meta-analysis on the role of children in SARS-CoV-2 in household transmission clusters Screening for depressive and anxiety symptoms during pregnancy and postpartum at a Japanese perinatal center Psychological status during the first trimester of pregnancy under the COVID-19 epidemic in Japan Seropositivity of influenza A H1NI in mothers and infants following maternal vaccination with trivalent seasonal influenza vaccine after the 2009 pandemic COVID-19 vaccine acceptance in pregnant women